Cetuximab and biomarkers in non-small-cell lung carcinoma

Cetuximab and biomarkers in non-small-cell lung carcinoma

Nitin Patil, Mohammed Abba, Heike AllgayerDepartment of Experimental Surgery, Medical Faculty Mannheim, University of Heidelberg and Molecular Oncology of Solid Tumors Unit, German Cancer Research Center (DKFZ), Heidelberg, GermanyAbstract: Cancer progression is a highly complex process that is driv...

Full description

Bibliographic Details
Main Authors:	Patil N, Abba M, Allgayer H
Format:	Article
Language:	English
Published:	Dove Medical Press 2012-07-01
Series:	Biologics : Targets & Therapy
Online Access:	http://www.dovepress.com/cetuximab-and-biomarkers-in-non-small-cell-lung-carcinoma-a10388

Similar Items

Rational use of cetuximab in the treatment of advanced non-small cell lung cancer
by: Charu Aggarwal, et al.
Published: (2009-08-01)

Efficacy of Cetuximab in Combination with Chemotherapy in Advanced Non-small Cell Lung Cancer
by: Sheng YANG, et al.
Published: (2016-05-01)

Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma
by: Olivia Leblanc, et al.
Published: (2020-02-01)

EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab
by: Chad A Reade, et al.
Published: (2009-05-01)

Effects of Monoclonal Antibody Cetuximab on Proliferation of Non-small Cell Lung Cancer Cell lines
by: Zhen CHEN, et al.
Published: (2010-08-01)

Immuno-PET imaging for non-invasive assessment of cetuximab accumulation in non-small cell lung cancer
by: Aiko Yamaguchi, et al.
Published: (2019-10-01)

A review of clinical trials of cetuximab combined with radiotherapy for non-small cell lung cancer
by: Nieder Carsten, et al.
Published: (2012-01-01)

Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth <it>in vivo</it>
by: Gurpide Alfonso, et al.
Published: (2010-06-01)

Combination of afatinib with cetuximab in patients with EGFR-mutant non-small-cell lung cancer resistant to EGFR inhibitors
by: Ribeiro Gomes J, et al.
Published: (2015-05-01)

Treatment of non-small cell lung cancer with intensity-modulated radiation therapy in combination with cetuximab: the NEAR protocol (NCT00115518)
by: Hoess A, et al.
Published: (2006-05-01)

LETM1 is a potential biomarker of prognosis in lung non-small cell carcinoma
by: Longzhen Piao, et al.
Published: (2019-09-01)

Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer
by: Fortunato Ciardiello, et al.
Published: (2020-10-01)

Biomarker testing in non-small cell lung carcinoma – More is better: A case series
by: Ullas Batra, et al.
Published: (2020-01-01)

P53 AND Ki67 BIOMARKERS AS PROGNOSTIC FACTORS OF NON SMALL CELL LUNG CARCINOMA
by: S. Saber, et al.
Published: (2005-04-01)

P53 AND Ki67 BIOMARKERS AS PROGNOSTIC FACTORS OF NON SMALL CELL LUNG CARCINOMA
by: S. Saber, et al.
Published: (2005-05-01)

Cost-Effectiveness of Cetuximab for Advanced Esophageal Squamous Cell Carcinoma.
by: Vincent T Janmaat, et al.
Published: (2016-01-01)

Cetuximab for the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
by: J Greenhalgh, et al.
Published: (2009-10-01)

Epigenetics in non-small cell lung carcinomas
by: Irlanda Peralta-Arrieta, et al.
Published: (2019-06-01)

Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab
by: Chen Gang, et al.
Published: (2012-03-01)

A pilot study (SWOG S0429) of weekly cetuximab and chest radiotherapy for poor-risk stage III non-small cell lung cancer
by: Yuhchyau eChen, et al.
Published: (2013-08-01)

Clinical Remission of Cutaneous Squamous Cell Carcinoma of the Auricle with Cetuximab and Nivolumab
by: Alessandra Chen, et al.
Published: (2018-01-01)

Cetuximab Rechallenge and Monotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck
by: Greg Knutzen, et al.
Published: (2015-11-01)

ANALYSIS OF IMMUNOREGULATORY BIOMARKERS IN NON-SMALL CELL LUNG CANCER
by: Usó Marco, Marta
Published: (2015)

Effect and biomarker of Nivolumab for non–small-cell lung cancer
by: Li Wang, et al.
Published: (2019-09-01)

Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer
by: Li Ruiyun, et al.
Published: (2010-07-01)

Correction to: Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab
by: Gang Chen, et al.
Published: (2020-02-01)

Comprehensive Characterization of Stage IIIA Non-Small Cell Lung Carcinoma
by: Singh N, et al.
Published: (2020-11-01)

Peripheral Blood Leukocyte N6-methyladenosine is a Noninvasive Biomarker for Non-small-cell Lung Carcinoma
by: Pei Y, et al.
Published: (2020-11-01)

Circulating Biomarkers for Early Stage Non-Small Cell Lung Carcinoma Detection: Supplementation to Low‐Dose Computed Tomography
by: Chin Fung Kelvin Kan, et al.
Published: (2021-04-01)

Targeted therapy of non-small-cell lung carcinoma
by: Divya Tiwari, et al.
Published: (2012-02-01)

Radiosensitization of non-small cell lung carcinoma by EGFR inhibition
by: Keta Otilija D., et al.
Published: (2014-01-01)

Recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck
by: Francesco Perri, et al.
Published: (2009-08-01)

Dramatic response of refractory metastatic squamous cell carcinoma of the skin with cetuximab/pembrolizumab
by: Candice Hober, et al.
Published: (2021-05-01)

Biomarkers for Non-Small Cell Lung Cancer: From the Bench to the Bedside
by: Ramon Andrade de Mello, et al.
Published: (2020-10-01)

Predicting Diagnostic Gene Biomarkers for Non-Small-Cell Lung Cancer
by: Bin Liang, et al.
Published: (2016-01-01)

Research Progress of Biomarkers for Immunotherapy on Non-small Cell Lung Cancer
by: JIANG Meilin, et al.
Published: (2018-10-01)

A retrospective evaluation of non-small cell lung carcinoma
by: Ali İnal, et al.
Published: (2012-12-01)

Personalized medicine and treatment approaches in non-small-cell lung carcinoma
by: Vadakara J, et al.
Published: (2012-09-01)

New Insights on Old Biomarkers Involved in Tumor Microenvironment Changes and Their Diagnostic Relevance in Non-Small Cell Lung Carcinoma
by: Katarzyna Wadowska, et al.
Published: (2021-08-01)

Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma
by: Xin-Min Yu, et al.
Published: (2016-11-01)